cysteine has been researched along with Thrombophilia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ivica, N; Pintarić, I; Titlić, M | 1 |
Djordjevic, V; Kovac, M; Mitic, G; Pruner, I; Radojkovic, D | 1 |
Dávid, M; Habon, T; Keszthelyi, Z; Kovács, N; Losonczy, H; Nagy, A; Tóth, O | 1 |
de Mazancourt, P; de Raucourt, E; Fischer, AM; Meyer, G | 1 |
1 review(s) available for cysteine and Thrombophilia
Article | Year |
---|---|
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Topics: Adult; C-Reactive Protein; Cholesterol; Cysteine; Female; Fibrin; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Pedigree; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Threonine; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2005 |
3 other study(ies) available for cysteine and Thrombophilia
Article | Year |
---|---|
MTHFR C677T and prothrombin G20210A mutations in a woman from Dalmatia with silent brain infarction. .
Topics: Alanine; Anticoagulants; Biomarkers; Brain Infarction; Croatia; Cysteine; Female; Glycine; Heterozygote; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Pedigree; Prothrombin; Threonine; Thrombophilia; Treatment Outcome | 2014 |
Are thrombophilia more multifactorial than we thought: report of mosaicism for FII G20210A and novel FII T20061C gene variants.
Topics: Alanine; Biomarkers; Cysteine; Female; Genotype; Glycine; Humans; Hypertension, Pulmonary; Middle Aged; Mosaicism; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prothrombin; Pulmonary Embolism; Recurrence; Risk Factors; Threonine; Thrombophilia | 2012 |
A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III).
Topics: Adult; Arginine; Cysteine; Fibrinogen; Heterozygote; Humans; Male; Mutation; Pedigree; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2006 |